SCHEMBL3043641

SCHEMBL3043641

O=C(NCc1ccccn1)c1ccc2[nH]c(-c3ccc(Cl)c4c3C(=O)NC4)cc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
KDM4E B2RXH2 3/20 0.48
KMT2A Q03164 1/20 0.46
ROCK2 O75116 2/20 0.43
ROCK1 Q13464 1/20 0.43
CHEK1 O14757 1/20 0.43
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
DRD2 P14416 1/20 0.42
NAMPT P43490 1/20 0.42
ALDH1A1 P00352 3/20 0.41
HTT P42858 2/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PRNP P04156 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3041991 0.92 LMNA (0.42) NPC1RAB9AKDM4EKMT2ANAMPT
SCHEMBL3046947 0.88 AURKA (0.46) NPC1RAB9AKMT2AALDH1A1GAA
SCHEMBL3051466 0.85 ALDH1A1 (0.42) KMT2AROCK2CHEK1NAMPTALDH1A1
SCHEMBL3046568 0.84 AURKA (0.44) KMT2ACYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL3044094 0.84 LMNA (0.48) KDM4EKMT2AROCK2ROCK1CYP1A2
SCHEMBL3041519 0.83 HPGD (0.45) KDM4EKMT2AALDH1A1HTTGAA
SCHEMBL27720746 0.83 KDM4E (0.46) NPC1RAB9AKDM4EKMT2AROCK2
SCHEMBL3043632 0.82 KDR (0.41) KDM4ECHEK1CYP1A2CYP3A4CYP2D6
SCHEMBL3039016 0.82 KDR (0.44) KDM4EKMT2AALDH1A1HTTPOLB
Hydrochloric Acid SCHEMBL3040466 0.82 KDR (0.42) KMT2ACHEK1CYP1A2AURKACDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 US disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054407-A1 Nitrogen-containing heterocyclic compound NR4A1, NR5A2, PRMT8 NPC1 1107/4885RAB9A 2603/4885KDM4E 488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.